Patricia Marañón, Carlos Ernesto Fernández-García, Stephania C. Isaza, Esther Rey, Rocío Gallego-Durán, Rocío Montero-Vallejo, . . . Águeda González-Rodríguez. (2022). Bone morphogenetic protein 2 is a new molecular target linked to non-alcoholic fatty liver disease with potential value as non-invasive screening tool. BMC.
Chicago Style (17th ed.) CitationPatricia Marañón, et al. Bone Morphogenetic Protein 2 Is a New Molecular Target Linked to Non-alcoholic Fatty Liver Disease with Potential Value as Non-invasive Screening Tool. BMC, 2022.
MLA (9th ed.) CitationPatricia Marañón, et al. Bone Morphogenetic Protein 2 Is a New Molecular Target Linked to Non-alcoholic Fatty Liver Disease with Potential Value as Non-invasive Screening Tool. BMC, 2022.
Warning: These citations may not always be 100% accurate.